Autograft Versus Calcium Phosphate Macroporous Bioceramics as Bone Substitute for Tibial Valgus Osteotomy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00200603 |
Recruitment Status
: Unknown
Verified May 2004 by Nantes University Hospital.
Recruitment status was: Active, not recruiting
First Posted
: September 20, 2005
Last Update Posted
: December 16, 2005
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Osteoarthritis of the Knee | Device: calcium phosphate macroporous bioceramics | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 50 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Autograft Versus Calcium Phosphate Macroporous Bioceramics as Bone Substitute for Tibial Valgus Osteotomy |
Study Start Date : | May 1999 |

- Radiological healing and stability of the osteotomy measure at 3, 6, 12 and 24 months after surgery
- Knee and iliac crest painSurgical complicationsFonctional results

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- knee osteoarthritis eligible for tibial valgus osteotomy
- > 18 y.o
Exclusion Criteria:
- prior tibial osteotomy
- history of local infection
- rheumatoid and other inflammatory arthritis

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00200603
France | |
Gouin François | |
Nantes, France, 44093 |
Principal Investigator: | François Gouin, MD | Nantes UH |
ClinicalTrials.gov Identifier: | NCT00200603 History of Changes |
Other Study ID Numbers: |
BRD/99/3-G |
First Posted: | September 20, 2005 Key Record Dates |
Last Update Posted: | December 16, 2005 |
Last Verified: | May 2004 |
Keywords provided by Nantes University Hospital:
Calcium phosphate ceramic tibial osteotomy osteoarthritis |
Additional relevant MeSH terms:
Osteoarthritis Osteoarthritis, Knee Arthritis Joint Diseases Musculoskeletal Diseases |
Rheumatic Diseases Calcium, Dietary Bone Density Conservation Agents Physiological Effects of Drugs |